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+ regulatory T (Treg) cells comprise a unique subset of T cells required for maintaining immune homeostasis. However, the molecular mechanisms associated with the functional variety of Treg cells are not fully delineated. In the present study, we demonstrate that ubiquitin-specific protease (USP)4 physically interacted with interferon regulatory factor 8 (IRF8) function via a K48-linked deubiquitinase, which stabilized IRF8 protein levels in Treg cells. Depletion of USP4 promoted the polyubiquitination of IRF8 and the upregulation of type 2 inflammatory cytokine gene expression in Treg cells. Consistently, treatment of Treg cells with USP4 inhibitor facilitated the polyubiquitination of IRF8. In addition, the deficiency of USP4 alleviated the suppressive function of Treg cells. Taken together, our results suggest that USP4 interacts with and stabilizes IRF8 to promote the suppressive function of Treg cells.
Keywords: IRF8; regulatory T cells; USP4 + regulatory T (Treg) cells, comprising a distinct member of the CD4 + T cell lineage family, play a pivotal role in remaining immune homeostasis [1] [2] [3] . Treg cells exert a suppressive function by multiple different mechanisms, including the secretion of anti-proinflammatory cytokines such as interleukin (IL)-10 and transforming growth factor (TGF)-b, the consumption of IL-2 and the regulation of the metabolism of effector T cells [4] . In addition, an impairment of the differentiation and function of Treg cells leads Abbreviations IL, interleukin; IRF8, interferon regulatory factor 8; TGF, transforming growth factor; Treg, regulatory T cell; USP, ubiquitin-specific protease.
to various immunodeficiency diseases, including pathogenic microbe infection, chronic inflammation and autoimmune diseases such as systemic lupus erythematosus, rheumatoid arthritis and multiple sclerosis [5, 6] .
It has been widely appreciated that Treg cells could not only arise from the thymus, but also in the periphery of na€ ıve CD4 + T cells under certain circumstances [7] . Treg cells could be generated in the thymus under a selective process via the expression of self-reactive T-cell antigen receptor (nature Treg) or undergo differentiation from na€ ıve CD4 + T cells in the periphery (induced Treg). However, a variety of arguable features associated with the phenotype and function could be used to distinguish between natural Treg and induced Treg cells [7] .
Interferon regulatory factor 8 (IRF8) has been widely recognized as one of the key lineage-determining transcription factors and plays a pivotal role in differentiation of T helper cells [8] . IRF8, induced by TCR engagement in T cells, exerts an influence on the differentiation of T helper cells [9] . Treg cells derived from Irf8 À/À mice exhibit aberrant expression of Il4 and Il17 as well as an impairment of suppressive function to regulate the Th1 response [10] . In addition, it has been shown that the function of IRF8 could be precisely regulated at the transcriptional level [11] . However, the factors that control the IRF8 post-translational modification and are involved in regulating its protein stability remain elusive. Protein ubiquitination is a catabolic process that is regulated by at least two main counterparts, including E3 ubiquitin ligases and deubiquitinating enzymes. E3 ubiquitin ligase attaches the ubiquitin to target the protein in lysine residues, which can be removed by deubiquitinating enzymes. The ubiquitination process participates in a variety of cell cycle mechanisms, such as protein trafficking, proteasomemediated proteolysis and functional regulation [12, 13] . The regulation of protein ubiquitination is involved in the function of FOXP3 + Treg cells. For example, Stub1 and Cbl-b, coordinately ubiquitinate FOXP3, thereby negatively regulating Treg cell suppressive function [14, 15] . By contrast, deubiquitination plays an opposite role in Treg cell function [16, 17] . Although it has been reported that IRF8 is a major regulator in function of Treg cells, the molecular regulation of IRF8 at the post-translational level has not been fully understood. There arẽ 100 deubiquitinating enzymes for regulating protein lysine ubiquitination, which is required for a host of intracellular process [12, 13] . Ubiquitin-specific protease (USP)4 reportedly acts as a proto-oncogene that mediates transport between nuclear and cytoplasmic via TGF-b [18] . Our recent studies have found that USP4 could deubiquitinate RORct to positively regulate Th17 function during inflammation [19] .
In the present study, we investigated the potential role of USP4 in the modification of IRF8 stability and function. We report that USP4 acts as a deubiquitinase for IRF8 and therefore stabilizes and contributes to deubiquitinating the Lys-48-linked polyubiquitination of IRF8. In addition, we provide evidence indicating that a deficiency in USP4 resulted in decreased IRF8 levels and the upregulation of inflammatory associated genes such as IL-4, IL-5 and IL-13. Furthermore, the depletion of USP4 alleviated Treg cellmediated suppressive function with respect to effector T cells. Thus, our work identifies USP4 as a novel positive regulator of IRF8 that is crucial for Treg cell function.
Materials and methods
Plasmids, antibodies and reagents USP4 and IRF8 were amplified from human peripheral blood mononuclear cells. The gene products were then cloned into pIPHA-tagged and pIPMyc-tagged vectors. The USP4C311A mutant was made by site-directed mutagenesis, which then was confirmed by DNA sequencing. 
Immunoprecipitation and immunoblotting
Cells were lysed in radioimmunoprecipitation (IP) assay buffer containing 135 mM NaCl, 20 mM Tris/HCl (pH 7.4), 1% Nonidet P-40, 0.5% sodium deoxycholate, 10% glycerol and 1 mM EDTA with 1 mM PMSF, 1 mM Na 3 VO 4 , 1 mM NaF and protease inhibitor (Sigma) for 30 min at 4°C. This was followed by centrifugation at 12 9 10 3 g for 15 min, and then the cell lysate supernatants were incubated with the indicated antibodies and the appropriate protein A/G Plus-agarose (Santa Cruz Biotechnology), followed by western blotting analysis in accordance with standard procedures.
His pull-down assay
Cells were pretreated with 20 nM MG132 for 4 h, and then harvested and washed with ice-cold PBS and lysed at room temperature for 30 min in urea buffer [8 M urea, 100 mM Na 2 HPO 4 , 10 mM Tris (pH 8.0), 0.2% Triton X-100, 10 mM imidazole], followed by incubation with nickelnitrilotriacetic acid beads for 2 h. The beads were washed in the order indicated, twice in urea buffer (pH 8.0), twice in urea buffer [10 mM Tris (pH 6.3), 8 M urea, 100 mM Na 2 HPO 4 , 0.2% Triton X-100 and 10 mM imidazole] (pH 6.0) and once in a wash buffer [20 mM Tris (pH 8.0), 100 mM NaCl, 20% glycerol, 1 mM dithiothreitol and 10 mM imidazole], followed by western blotting.
RNA isolation and RT-PCR
Total RNAs were extracted from Treg cells using TRIzol reagent (Invitrogen) in accordance with manufacturer's instructions. Then, the RNA was quantified and reversetranscribed into complementary DNA (PrimeScript RT reagent kit; Takara Bio Inc., Otsu, Japan). PCR reactions were performed on the ABI 7900HT sequence detection system (Applied Biosystems, Foster City, CA, USA) using SYBR Green mix (Takara). The indicated mRNA expression levels were normalized with b-actin expression. The primers using in the real-time PCR were: USP4: 5 0 -ACC shRNA lentiviral vector construction and transduction shRNA sequences were synthesized by Shanghai Sunny Biotechnology Co. Ltd (Shanghai, China), followed by cloning of the oligos into the shRNA lentiviral vector PLKO.1. The PLKO.1-shUSP4, del8.9 and vesicular stomatitis virus G were co-transfected into HEK293T cells. After 48 h of transfection, the supernatants with lentivirus containing shUSP4 were harvested for a knockdown assay. Treg cells were infected using lentivirus supernatants containing 8 mgÁmL À1 polybrene overnight, which were replaced with fresh medium on day 2. Meanwhile, puromycin was added to select transduced cells on day 3. The shUSP4 sequences were: shUSP4-1:
In vitro suppression assay
Treg cells were infected as above described or pretreated with USP4 inhibitor for 12 h. Before incubation, human effector T cells were labeled with 5 lM CTV (Invitrogen) for 15 min at 37°C, followed by co-culture with pretreated Treg cells and anti-CD3/Cd28 beads at different ratios in a U-bottom 96-well plate. Four days later, total cells were harvested for staining with viability dye (fixable viability dye, eFluor 780Ò; eBioscience) and then analyzed on a Fortessa cytometer (BD Biosciences). 
Results

USP4 interacts with IRF8
Our previous study has shown that the E3 deubiquitinase USP4 has an important role in the development and function of Th17 cells via deubiquitinating RORct [19] . In the present study, we were interested in the potential role of USP4 in Treg cells. Given that Irf8
À/ À Treg cells exhibit an impairment of suppressive function [10] , we intended to investigate whether the protein stability and activity of IRF8 is also regulated by protein post-translational modification enzymes such as USP4. We first set out to examine whether USP4 could interact with IRF8. Expression vectors containing Myc-tagged USP4 and HA-tagged IRF8 were cotransfected into HEK293T cells for co-IP analysis. The results demonstrated that USP4 could interact with IRF8 in reciprocal fashion (Fig. 1A,B ). In addition, such an interaction was also confirmed at the endogenous level in human primary Treg cells, which indicates a potential interaction between those two proteins (Fig. 1C) . To determine which domain in USP4 contributes to the interaction, we co-transfected Myc-tagged IRF8, HA-tagged, full-length USP4 or several truncation mutants (1-260, 261-963) into HEK293T cells, which was followed by a co-IP experiment. The results revealed that the C-terminal domain of USP4 interacts with IRF8 (Fig. 1D) . Meanwhile, to examine which domain in IRF8 was responsible for the interaction to USP4, we generated a panel of IRF8 truncation expression constructs. We then performed a co-IP experiment. The results showed that the C-terminal domain of IRF8 was crucial for the interaction between IRF8 and USP4 (Fig. 1E ). Taken together, these results show that USP4 interacts with IRF8 in Treg cells.
USP4 stabilizes IRF8
Considering the functional interaction between those two proteins, we then tested whether USP4 plays a role in positively regulating IRF8 stability. Myc-tagged IRF8 and HA-tagged USP4 or a controlled HA vector were co-transfected into HEK293T cells, followed by western blotting analysis. The results showed that USP4 significantly upregulated the protein level of IRF8 in a dose-dependent manner ( Fig. 2A) . To further confirm these results, we treated the transfected IRF8 protein levels at the indicated time points were normalized to the protein density at 0 h. Data are representative of more than three independent experiments. Error bars indicate the mean AE SD. **P < 0.01. CA, C311A. HEK293T cells with the protein synthesis inhibitor cycloheximide (CHX) for the indicated times, followed by an analysis of the IRF8 protein level. We observed that the half-life of IRF8 protein was significantly prolonged in the presence of USP4 but not the enzymatic inactive mutant USP4C311A (Fig. 2B ).
USP4 stabilizes IRF8 by deubiquitination of K48-linked polyubiquitination
Considering that there are seven lysine residues in the ubiquitin molecule (Lys-6, Lys-11, Lys-27, Lys-29, Lys-33, Lys-48 and Lys-63), ubiquitin monomers could exhibit a definitive function by forming different polyubiquitin chains. Currently, the ubiquitination of Lys-48
and Lys-63 linkage has been best identified. It was reported that Lys-48-linked polyubiquitin chains contribute to proteasome-dependent degradation of modified protein [12] . By contrast, Lys-63-linked polyubiquitin chains were widely involved in multiintracellular process associated with nonproteolytic signals. To determine whether USP4 mediates the deubiquitination of IRF8, IRF8 expressing plasmids were cotransfected with either wild-type USP4 expressing plasmid or its inactive-enzymes mutant USP4C311A into HEK293T cells. As expected, we found that USP4 could significantly promote the deubiquitination of IRF8 (Fig. 3A) . To further determine which type of polyubiquitin chain of IRF8 is removed by USP4, we co-transfected IRF8 with the Lys-48 only (K48 only) or Lys-63 only (K63 only) ubiquitin mutant, followed by a pull-down assay. We found that IRF8 was more heavily deubiquitinated by USP4 with the Lys-48 only mutant but not the Lys-63 only (Fig. 3B) . Such deubiquitination was also confirmed in Treg cells, in which knockdown of USP4 significantly increased the ubiquitination of IRF8 (Fig. 3C) . To determine whether the enzymatic activity of USP4 affects IRF8 polyubiquitination, we treated Treg cells with Vialinin A, a UPS4 enzyme activity inhibitor and, consequently, we detected less ubiquitinated IRF8, followed by a decreased IRF8 protein level (Fig. 3D) . Taken together, these data reveal that USP4 stabilizes IRF8 protein through Lys-48-linked deubiquitination, which could prevent proteasome-dependent degradation of IRF8.
USP4 depletion bestows Treg aberrant expression of the type 2 inflammatory cytokine gene
To explore whether USP4 and IRF8 co-express in Treg cells, human na€ ıve CD4 + cells were polarized under the conditions of Th0, Th1, Th2, Th17 and Treg cells, respectively. The protein levels of USP4 and IRF8 in Treg cells were higher compared to other helper T cell subsets (Fig. 4A) . To further evaluate the role of USP4 in Treg cells, lentivirus containing shUSP4-1 or shUSP4-2 was transduced into Treg cells. An absence of USP4 significantly decreased the protein level of IRF8 (Fig. 4B) . Interestingly, the expression of several inflammation related cytokine genes, such as IL-4, IL-5 and IL-13, was upregulated after knocking down USP4 (Fig. 4C) . Collectively, these data suggest that USP4 positively regulates IRF8 function with respect to Treg cells.
USP4 depletion negatively controls Treg cell suppression function
To further investigate the role of USP4 in Treg cells, we performed a function assay in which the suppressive function of Treg cells was detected with the standard cell co-culture system in vitro. In the experiment, USP4 gene expression in Treg cells was first knocked down prior to the suppressive assay. Human freshly isolated CD4 + effector T cells were labeled with CTV before being co-cultured with Treg cells at the indicated ratios, followed by stimulation of anti-CD3/ CD28 beads for 4 days. The results showed that the proliferation of CD4 + effector T cells co-cultured with USP4 knockdown Treg cells was stronger compared to the CD4 + effector T cells with control Treg cells (Fig. 5A) . Consistently, Vialinin A pretreated Treg cells also displayed an increased suppressive function (Fig. 5B) . Therefore, these data suggest that USP4 promotes the suppressive function of Treg cells partly via affecting the deubiquitination of IRF8. 
Discussion
The interferon regulatory factor family has been broadly identified as an important regulator in the differentiation of T helper cells [8] . Irf8 À/À Treg cells were recently shown to unable to suppress effector T cells [10] . However, the post-transcriptional modification of IRF8 is not fully characterized. Several studies have demonstrated that deubiquitinases may play a critical role in Treg cell function [14] [15] [16] [17] . In the present study, we found that a deubiquitination-specific protease, USP4, interacts with IRF8 to promote its deubiquitination. Moreover, we showed that USP4 stabilized IRF8 and facilitated its functional effect in Treg cell-mediated in vitro immune suppression. Previous studies have suggested that protein ubiquitination may play an important role in regulating the differentiation and function of multiple CD4 + T cell subsets. For example, deubiquitinase USP7 stabilizes FOXP3 to enhance the suppressive function of Treg cells [16] . By contrast, Stub1, an E3 ligase, negatively regulates Treg cell function by ubiquitinating and destabilizing FOXP3 [14] . In addition, the counter effect between E3 ligase Mdm2 and the deubiquitinase USP21 regulates Th2 cell function by controlling the stability of GATA3 [20, 21] . Previous studies have demonstrated that USP4 is considered as an oncogene by deubiquitinating TGF-b type I receptor, which leads to epithelial mesenchymal transition and metastasis [18] . Meanwhile, USP4 regulates protein expression in a stabilization-dependent manner, such as by USP4 removing the K48-ubiquitin chains from RORct [19] . In the present study, we found that USP4 could interact and regulate the stability of IRF8 by K48-linked deubiquitination. IRF8 became more stable in USP4 overexpressing cells ( Fig. 2A,B) , whereas IRF8 was downregulated in USP4 knockdown Treg cells (Fig. 4B) . Furthermore, ectopic expression of USP4 could remove the K48-ubiquitin chains of IRF8 but not USP4C311A (Fig. 3A) . Consistently, the ubiquitination of IRF8 was increased in USP4 knockdown Treg cells (Fig. 3C,D) . These data suggest that USP4 is able to stabilize IRF8 through deubiquitination. Moreover, both USP4 knockdown and its inhibitor Vialilin A pretreated Treg cells exhibited an impairment of suppressive function (Fig. 5A,B) . Nothing is yet known regarding the molecular mechanism by which IRF8 promotes Treg function and our data suggest that this may be partially mediated by transcriptional suppression of the type 2 inflammatory cytokine gene (Fig. 4C) . Our data also indicate that USP4 may positively regulate Treg cell-mediated in vitro suppressive function by deubiquitinating IRF8.
A recent study reported that USP4 could facilitate Th17 differentiation and function via deubiquitinating RORct [19] . Our studies suggest that deubiquitination of IRF8 by USP4 positively regulates Treg cells. These results indicate that USP4 may play an important role in the plasticity between Th17 and Treg cells, although the molecular mechanism responsible for this requires further study.
Taken together, the results obtained in the present study reveal that USP4 interacts with and stabilizes IRF8 in Treg cells and promotes its suppressive function. It is interesting that IRF8 is also expressed in B cells, dendritic cells and macrophages, as confirmed previously and also shown to have a crucial role in the immune response [22] [23] [24] . It is possible that USP4 may also affect immune cell function via deubiquitination of IRF8.
